Synopsys

Synopsys reported results (Aug 26, 2026). EPS came in at $3.91 against a $3.67 consensus, beat by 6.5%. Revenue was $2.5B versus $2.4B expected, beat by 1.6%.

Synopsys reported a solid Q2 FY2026, with both revenue and EPS exceeding street estimates. The company's strong performance is underpinned by a strong backlog and optimistic guidance, reflecting continued demand for its EDA and IP solutions.

Synopsys cleared the quarter on EPS by +5.9% while revenue beat by only +0.8%, and the variant read is that investors should not pay for a clean demand acceleration but also should not dismiss the print as low-quality timing. What the market may be missing is that Ansys timing pulled revenue forward, yet $11.3 billion of backlog, 42.1% non-GAAP operating margin, and the unchanged free cash flow framework give management enough visibility to defend FY2026 earnings even as reported gross margin sits far below the pre-Ansys history.

Synopsys gave investors a small revenue surprise and a cleaner EPS beat, yet the actionable point is that FY2026 guidance shifted the debate from China and IP cyclicality to whether $11.4 billion of backlog can convert with 40.5% non-GAAP operating margin. The market was set up for a modest beat; what it may be underpricing is the operating leverage embedded in ANSYS integration and cost synergy acceleration, even as gross margin dilution makes the quality of growth look worse on the surface.

The market was set up for a clean AI-design-tools beat, but Synopsys delivered a -1.6% revenue miss and -10.8% EPS miss because Design IP and deal financing absorbed the upside. The variant view is that the print should not be traded as a broad EDA slowdown: design automation is still compounding, while the investable question has shifted to whether IP margin and ANSYS integration can stop diluting the model by Q4 FY2025.